top of page

Illuminating New Pathways to Intervention 

What makes EarGenie® different 

Our EarGenie® prototype, currently in clinical trial, is the first fNIRS device designed for clinical use in audiology clinics. Our techniques accurately and objectively measure hearing and speech discrimination, supporting critical unmet needs in clinical practice. With EarGenie, our aim is to provide:

  • Assessment of the functional hearing of babies with auditory neuropathy.

  • Objective programming of cochlear implants and validation of hearing device programs.

  • Evaluation, using our speech discrimination test, of whether an infant’s hearing aids are supporting language development, thus leading to earlier referral for cochlear implantation when appropriate.

  • Objective measurement of speech discrimination in children with language delay to help speech pathologists provide the most effective therapy.

EarGenie system Photo of equipment set up.jpg

EarGenie®:

  • Uses advanced algorithms with proven accuracy to analyze auditory responses rapidly and automatically

  • Is designed to be baby friendly and easy to use

  • Features an intuitive user interface for ease of clinical use

What we measure

EarGenie® uses functional near-infrared spectroscopy (fNIRS) to measure how well a baby or child can hear and distinguish between different speech sounds. 

fNIRS is a, non-invasive brain imaging technique using light in the near-infrared spectrum to measure brain activity. It works by measuring changes in the concentration of oxygenated and deoxygenated haemoglobin in the brain. 

  • Light passes harmlessly from sources placed on the scalp through the brain. 

  • Light returning to the scalp is detected by sensitive sensors. 

  • Areas of the brain activated by sound will show changes in oxygenated and deoxygenated haemoglobin level. 

  • Using our proprietary algorithm, we can measure these haemoglobin changes. 

Untitled design (14)_edited.png

The brain's hearing and language centres are imaged

Our research

White paper

2023

A reliable, accurate, and clinic-friendly objective test of speech sound detection and discrimination in sleeping infants.

McKay, C.M., Wunderlich, J., Mao, D., Balasubramanian, G., Lee, O.W., Gao, D., & McDonald, L.

Journal articles

2024

Two independent response mechanisms to auditory stimuli measured with fNIRS in sleeping infants.

Lee, O. W., Mao, D., Wunderlich, J., Balasubramanian, G., Haneman, M., Korneev, M., & McKay, C.M.

2023

The Use of Heart Rate Responses Extracted from Functional Near-Infrared Spectroscopy Data as a Measure of Speech Discrimination Ability in Sleeping Infants. Ear and Hearing, 2023 14.

​Lee, O.W., Mao, D., Savkovic, B., Wunderlich, J., Nicholls, N., Jeffreys, E., Eager, M., Korneev, M., McKay, C.M.

Recent presentations and posters

2024

The role of functional near-infra-red spectroscopy (fNIRS) in early intervention for infants with hearing impairment.

2024

From the Lab to the Clinic: Using fNIRS to Accelerate Early Intervention for Infants with Hearing Loss

2024

Characterizing the morphology of auditory evoked loudness dependent fNIRS responses in sleeping infants

2024

EarGenie - A clinician-friendly fNIRS system to evaluate infant speech detection & discrimination

2024

EarGenie®, an innovative fNIRS device to measure infants brain response to sound.

bottom of page